These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 10411089

  • 1. In vivo description of dendritic cells in human renal cell carcinoma.
    Schwaab T, Schned AR, Heaney JA, Cole BF, Atzpodien J, Wittke F, Ernstoff MS.
    J Urol; 1999 Aug; 162(2):567-73. PubMed ID: 10411089
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D, Marković-Lipkovski J, Hadzi-Djokić J, Müller GA, Müller CA.
    Neoplasma; 1999 Aug; 46(3):173-8. PubMed ID: 10613593
    [Abstract] [Full Text] [Related]

  • 3. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
    Ayari C, LaRue H, Hovington H, Decobert M, Harel F, Bergeron A, Têtu B, Lacombe L, Fradet Y.
    Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487
    [Abstract] [Full Text] [Related]

  • 4. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT, Gessner A, Miller TP, Hersh EM, Johnson CS, Cui H, Frutiger Y, Grogan TM.
    Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
    [Abstract] [Full Text] [Related]

  • 5. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A.
    Cancer Res; 2001 Nov 01; 61(21):7925-33. PubMed ID: 11691814
    [Abstract] [Full Text] [Related]

  • 6. Morphological characteristics and co-stimulatory molecule (CD80, CD86, CD40) expression in tumor infiltrating dendritic cells in human endometrioid adenocarcinoma.
    Jia J, Wang Z, Li X, Wang Z, Wang X.
    Eur J Obstet Gynecol Reprod Biol; 2012 Feb 01; 160(2):223-7. PubMed ID: 22142817
    [Abstract] [Full Text] [Related]

  • 7. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
    Li CD, Zhang WY, Yuan CL, Han LY.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 10; 89(9):630-4. PubMed ID: 19595165
    [Abstract] [Full Text] [Related]

  • 8. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A, Tötterman TH, Böhle A, Brandau S.
    Cancer Gene Ther; 2002 Oct 10; 9(10):846-53. PubMed ID: 12224026
    [Abstract] [Full Text] [Related]

  • 9. Tumor infiltrating dendritic cells predict treatment response to immmunotherapy in patients with metastatic renal cell carcinoma.
    Kobayashi M, Suzuki K, Yashi M, Yuzawa M, Takayashiki N, Morita T.
    Anticancer Res; 2007 Oct 10; 27(2):1137-41. PubMed ID: 17465253
    [Abstract] [Full Text] [Related]

  • 10. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
    Menetrier-Caux C, Thomachot MC, Alberti L, Montmain G, Blay JY.
    Cancer Res; 2001 Apr 01; 61(7):3096-104. PubMed ID: 11306493
    [Abstract] [Full Text] [Related]

  • 11. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K, Teramoto K, Ozaki Y, Sawai S, Tezuka N, Ishida H, Kajino K, Fujino S, Yamauchi A, Taguchi O, Kannagi R, Yokomise H, Ogasawara K.
    Oncol Rep; 2007 Apr 01; 17(4):895-902. PubMed ID: 17342333
    [Abstract] [Full Text] [Related]

  • 12. HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation.
    Brasanac D, Müller CA, Müller GA, Hadzi-Dzokic J, Markovic-Lipkovski J.
    J Exp Clin Cancer Res; 1999 Dec 01; 18(4):505-10. PubMed ID: 10746977
    [Abstract] [Full Text] [Related]

  • 13. Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.
    Gigante M, Mandic M, Wesa AK, Cavalcanti E, Dambrosio M, Mancini V, Battaglia M, Gesualdo L, Storkus WJ, Ranieri E.
    J Immunother; 2008 Apr 01; 31(3):254-62. PubMed ID: 18317362
    [Abstract] [Full Text] [Related]

  • 14. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B, Siegel SE, Kaiser HE.
    In Vivo; 2004 Apr 01; 18(1):81-100. PubMed ID: 15011756
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic significance of CD83 positive tumor-infiltrating dendritic cells and expression of TGF-beta 1 in human gastric cancer.
    Ananiev J, Gulubova MV, Manolova IM.
    Hepatogastroenterology; 2011 Apr 01; 58(110-111):1834-40. PubMed ID: 22086706
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma.
    Furihata M, Ono Y, Ichikawa K, Tomita S, Fujimori T, Kubota K.
    Oncol Rep; 2005 Aug 01; 14(2):353-6. PubMed ID: 16012714
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Peptidome from renal cell carcinoma contains antigens recognized by CD4+ T cells and shared among tumors of different histology.
    Tassi E, Facchinetti V, Seresini S, Borri A, Dell'antonio G, Garavaglia C, Casorati G, Protti MP.
    Clin Cancer Res; 2006 Aug 15; 12(16):4949-57. PubMed ID: 16914584
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.